-
1
-
-
0023232859
-
Critical issues in cyclosporine monitoring: Report of the task force on cyclosporine monitoring
-
Shaw LM, Bowers L, Demers L, et al.: Critical issues in cyclosporine monitoring: Report of the task force on cyclosporine monitoring [Special Report]. Clin Chem 33:1269-1288, 1987
-
(1987)
Clin Chem
, vol.33
, pp. 1269-1288
-
-
Shaw, L.M.1
Bowers, L.2
Demers, L.3
-
2
-
-
0023508097
-
Cyclosporine: Structure, pharmacokinetics, and therapeutic drug monitoring
-
Vine W, Bowers LD: Cyclosporine: Structure, pharmacokinetics, and therapeutic drug monitoring. Crit Rev Clin Lab Sci 25:275-311, 1987.
-
(1987)
Crit Rev Clin Lab Sci
, vol.25
, pp. 275-311
-
-
Vine, W.1
Bowers, L.D.2
-
3
-
-
0023370667
-
Cyclosporine-induced acute renal dysfunction in the rat
-
English J, Evan A, Houghton DC, Bennett WM: Cyclosporine-induced acute renal dysfunction in the rat. Transplantation 44:135-141, 1987.
-
(1987)
Transplantation
, vol.44
, pp. 135-141
-
-
English, J.1
Evan, A.2
Houghton, D.C.3
Bennett, W.M.4
-
4
-
-
0027156733
-
Morphology of ischemic acute renal failure, normal function and cyclosporine toxicity in cyclosporine-treated renal allograft recipients
-
Solez K, Rocusen LC, Marcussen N, et al.: Morphology of ischemic acute renal failure, normal function and cyclosporine toxicity in cyclosporine-treated renal allograft recipients. Kidney Int 43:1058-1067, 1993
-
(1993)
Kidney Int
, vol.43
, pp. 1058-1067
-
-
Solez, K.1
Rocusen, L.C.2
Marcussen, N.3
-
5
-
-
0028863807
-
Alternative CsA metabolic pathways and toxicity
-
Christians U, Sewing KF: Alternative CsA metabolic pathways and toxicity. Clin Biochem 28:547-59, 1995.
-
(1995)
Clin Biochem
, vol.28
, pp. 547-559
-
-
Christians, U.1
Sewing, K.F.2
-
6
-
-
0025997099
-
Cyclosporine metabolite pattern in blood and urine of liver graft recipient: Association of cyclosporine metabolites with nephrotoxicity
-
Christians U, Kolhaw R, Budniak J, et al.: Cyclosporine metabolite pattern in blood and urine of liver graft recipient: Association of cyclosporine metabolites with nephrotoxicity. Eur J Clin Pharmacol 41:285-290, 1991.
-
(1991)
Eur J Clin Pharmacol
, vol.41
, pp. 285-290
-
-
Christians, U.1
Kolhaw, R.2
Budniak, J.3
-
7
-
-
0028824489
-
Lake Louise Conference on CsA monitoring in organ transplantation: Report of the consensus panel
-
Oellerich M, Armstrong VM, Kahan B, et al.: Lake Louise Conference on CsA monitoring in organ transplantation: Report of the consensus panel. Ther Drug Monit 17:642-654, 1995.
-
(1995)
Ther Drug Monit
, vol.17
, pp. 642-654
-
-
Oellerich, M.1
Armstrong, V.M.2
Kahan, B.3
-
8
-
-
0026447540
-
Measurement of cyclosporine by liquid chromatography and three immunoassays in blood from liver, cardiac, and renal transplant recipients
-
McBride JH, Kim SS, Rodgerson DO, Reyes AF, Ota MK: Measurement of cyclosporine by liquid chromatography and three immunoassays in blood from liver, cardiac, and renal transplant recipients. Clin Chem 38:2300-2306, 1992.
-
(1992)
Clin Chem
, vol.38
, pp. 2300-2306
-
-
McBride, J.H.1
Kim, S.S.2
Rodgerson, D.O.3
Reyes, A.F.4
Ota, M.K.5
-
9
-
-
0023488849
-
Automated solid-phase extraction and liquid chromatography for assay of cyclosporine in whole blood
-
Kabra PM, Wall JH, Dimson P: Automated solid-phase extraction and liquid chromatography for assay of cyclosporine in whole blood. Clin Chem 33:2272-2274, 1987.
-
(1987)
Clin Chem
, vol.33
, pp. 2272-2274
-
-
Kabra, P.M.1
Wall, J.H.2
Dimson, P.3
-
10
-
-
0013525020
-
Evaluation of the new cyclosporine monoclonal antibody fluorescent polarization immunoassay in cardiac and renal transplants
-
Schroeder T, Vine W, Ruckrigl D, Pesce A, Bhat G, First R: Evaluation of the new cyclosporine monoclonal antibody fluorescent polarization immunoassay in cardiac and renal transplants [Abstract]. Clin Chem 37:990, 1991.
-
(1991)
Clin Chem
, vol.37
, pp. 990
-
-
Schroeder, T.1
Vine, W.2
Ruckrigl, D.3
Pesce, A.4
Bhat, G.5
First, R.6
-
11
-
-
0029817346
-
Toxic effects of immunosuppressive drugs: Mechanisms and strategies for controlling them
-
Shaw LM, Kaplan B, Kaufman D: Toxic effects of immunosuppressive drugs: Mechanisms and strategies for controlling them. Clin Chem 42:1316-1321, 1996
-
(1996)
Clin Chem
, vol.42
, pp. 1316-1321
-
-
Shaw, L.M.1
Kaplan, B.2
Kaufman, D.3
-
12
-
-
0025308872
-
A monoclonal antibody fluorescent polarization immunoassay for cyclosporine
-
Wang P, Meucci V, Simpson E, et al.: A monoclonal antibody fluorescent polarization immunoassay for cyclosporine. Transplant Proc 22:1186-1188, 1990.
-
(1990)
Transplant Proc
, vol.22
, pp. 1186-1188
-
-
Wang, P.1
Meucci, V.2
Simpson, E.3
-
13
-
-
0019412879
-
Fluorescence polarization immunoassay III: An automated system for therapeutic drug determinations
-
Jolley ME, Stroupe SD, Schwenzer KS, et al.: Fluorescence polarization immunoassay III: an automated system for therapeutic drug determinations. Clin Chem 27:1575-1579, 1981.
-
(1981)
Clin Chem
, vol.27
, pp. 1575-1579
-
-
Jolley, M.E.1
Stroupe, S.D.2
Schwenzer, K.S.3
-
14
-
-
0024365391
-
Measurement of cyclosporine in plasma from patients with various transplants: HPLC and radioimmunoassay with a specific monoclonal antibody compared
-
McBride JH, Rodgerson DO, Park SS, Reyes AF: Measurement of cyclosporine in plasma from patients with various transplants: HPLC and radioimmunoassay with a specific monoclonal antibody compared. Clin Chem 35:1726-1730, 1989.
-
(1989)
Clin Chem
, vol.35
, pp. 1726-1730
-
-
McBride, J.H.1
Rodgerson, D.O.2
Park, S.S.3
Reyes, A.F.4
-
15
-
-
0024476756
-
Calibration of 1251 immunoassay measuring cyclosporin A
-
Krepil J, McPhillips M: Calibration of 1251 immunoassay measuring cyclosporin A Clin Chem 35:181-182, 1989.
-
(1989)
Clin Chem
, vol.35
, pp. 181-182
-
-
Krepil, J.1
McPhillips, M.2
-
16
-
-
0028812790
-
Analytic requirements for immunosuppressive drugs in clinical trials
-
Shaw LM, Annesley TM, Kaplan B, Brayman K: Analytic requirements for immunosuppressive drugs in clinical trials. Ther Drug Monit 17:577-583, 1995.
-
(1995)
Ther Drug Monit
, vol.17
, pp. 577-583
-
-
Shaw, L.M.1
Annesley, T.M.2
Kaplan, B.3
Brayman, K.4
|